Neurodegenerative diseases occur more frequently in patients with inflammatory gastrointestinal diseases including IBD or CeD, while ASAH2 has been discovered in Parkinson’s disease (Blokhin et al., 2022) and Alzheimer’s disease (Avramopoulos et al., 2007). This evidence concerns the gene ASAH2 and inflammatory bowel disease.